Quinnova Pharmaceuticals

About:

Quinnova Pharmaceuticals is a biotech company engaged in the development and commercialization of prescription drug products.

Website: http://www.quinnova.com

Top Investors: H.I.G. Capital, Safeguard Scientifics, Thomas, McNerney & Partners

Description:

Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercial sale of prescription drug products based on dermal drug delivery platforms. It offers HYDRO 40 foam, a dry skin treatment product; tersi foam, a leave-on foam indicated for the treatment of seborrheic dermatitis and tinea versicolor; rinnovi nail system, a prescription nail system that is designed to clean, treat, and protect diseased, damaged, brittle, and ingrown nails; and cleanse and treat, a pad delivery technology system for the treatment of acne. Quinnova Pharmaceuticals, Inc. was founded in 2003 and is based in Newtown, Pennsylvania.

Total Funding Amount:

$31.3M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Newtown, Pennsylvania, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)quinnova.com

Founders:

Christopher S. Brennan, Jeffrey S. Day

Number of Employees:

51-100

Last Funding Date:

2010-09-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai